Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 12137
TargetCoagulation factor XI(Human)
China Resources Biopharmaceutical Company

US Patent
LigandPNGBDBM682006(US12018027, Compound 2-1)
Affinity DataIC50: 3.39nMAssay Description:Experimental method:1) Preparation for compoundsAll test compounds were prepared using Echo, subjected to gradient dilution and transferred to a 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
China Resources Biopharmaceutical Company

US Patent
LigandPNGBDBM682017(US12018027, Compound 3-1)
Affinity DataIC50: 3.81nMAssay Description:Experimental method:1) Preparation for compoundsAll test compounds were prepared using Echo, subjected to gradient dilution and transferred to a 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
China Resources Biopharmaceutical Company

US Patent
LigandPNGBDBM681993(US12018027, Compound 1-2)
Affinity DataIC50: 3.90nMAssay Description:Experimental method:1) Preparation for compoundsAll test compounds were prepared using Echo, subjected to gradient dilution and transferred to a 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
China Resources Biopharmaceutical Company

US Patent
LigandPNGBDBM682019(US12018027, Compound 5-1)
Affinity DataIC50: 8.22nMAssay Description:Experimental method:1) Preparation for compoundsAll test compounds were prepared using Echo, subjected to gradient dilution and transferred to a 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
China Resources Biopharmaceutical Company

US Patent
LigandPNGBDBM682007(US12018027, Compound 2-2)
Affinity DataIC50: 10.7nMAssay Description:Experimental method:1) Preparation for compoundsAll test compounds were prepared using Echo, subjected to gradient dilution and transferred to a 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
China Resources Biopharmaceutical Company

US Patent
LigandPNGBDBM682020(US12018027, Compound 6-2)
Affinity DataIC50: 20.4nMAssay Description:Experimental method:1) Preparation for compoundsAll test compounds were prepared using Echo, subjected to gradient dilution and transferred to a 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
China Resources Biopharmaceutical Company

US Patent
LigandPNGBDBM682018(US12018027, Compound 4-1)
Affinity DataIC50: 21.7nMAssay Description:Experimental method:1) Preparation for compoundsAll test compounds were prepared using Echo, subjected to gradient dilution and transferred to a 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
Go to US Patent

TargetCoagulation factor XI(Human)
China Resources Biopharmaceutical Company

US Patent
LigandPNGBDBM682003(US12018027, Compound 1-4)
Affinity DataIC50: 34.1nMAssay Description:Experimental method:1) Preparation for compoundsAll test compounds were prepared using Echo, subjected to gradient dilution and transferred to a 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
Go to US Patent